Scripta Insights, a digital health company focused on pharmacy navigation, is teaming up with Mark Cuban Cost Plus Drug Company to bring transparent drug pricing to patients. Scripta will integrate Cost Plus Drugs’ discounted pricing into its platform Med Mapper, which the company said maps every drug on the market to every possible way users ...

Lobbying groups representing different camps of the healthcare industry have come together to urge the Centers for Medicare & Medicaid Service (CMS) to reconsider “conflicting regulatory proposals” that require different electronic standards for electronic data exchanges during prior authorization. The American Hospital Association, the American Medical Association and the Blue Cross Blue Shield Association’s joint ...

KFF research has consistently found prescription drug costs to be an important health policy area of public interest and public concern. Below are some key findings on the public’s experience with and perceptions of prescription drugs and their prices. For public awareness of some of the prescription drug cost provisions included in the 2022 Inflation ...

Hospitals charge commercial health plans two to three times more than what they charge the same insurer’s Medicare Advantage plans for the same procedure, a new study in Health Affairs found. Why it matters: While it’s well established that private plans are typically charged more than Medicare, this study leverages the latest available pricing data to shed light on differing dynamics between ...

Maintaining a healthy weight and body image undoubtedly improves self-esteem. But as we get older, keeping off the pounds and staying fit can seem like a full-time job.

Drugmakers around the globe are bracing for a major shakeup in how one of their largest customers does business. On Sept. 1, Medicare will target its first 10 drugs for historic price negotiations. The medications are sure to be among the country's costliest and will likely include common treatments for cancer and diabetes.